Dieter Haemmerich

At OncoBLAZE, we aim to develop innovative technologies that deliver therapy precisely to cancer cells that remain after surgery. We are committed to improving patient outcomes and reducing the burden of cancer recurrence. Our mission drives us to continuously innovate and collaborate with stakeholders to address unmet needs in cancer care, ultimately striving for a future where every patient receives personalized and effective treatment.